Inspira™ Partners with Westchester Medical Center on ART100 Evaluation
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, Nasdaq: IINNW) is excited to announce a strategic collaboration with Westchester Medical Center, a leading hospital known for advanced medical care. This partnership aims to evaluate the functionality and performance of the INSPIRA™ ART100 systems in real clinical scenarios. This collaboration highlights Inspira's commitment to enhancing respiratory treatments and advancing patient care.
Evaluating Innovative Technology in Real-World Settings
Westchester Medical Center has agreed to assess the newly FDA-cleared INSPIRA ART100 system in various clinical situations, allowing top-tier physicians to review its effectiveness in patient care. This evaluation is vital as it will expose Inspira's pioneering technologies to a network of leading medical professionals dedicated to patient outcomes.
Driving Advances in Patient Care
Through this collaboration, Inspira Technologies and Westchester Medical Center intend to explore the potential for long-term success, aiming for the future deployment of the next-generation INSPIRA™ ART systems, which are currently in development. The INSPIRA™ ART system is specifically designed to address acute respiratory failure, providing a unique treatment option that enhances patient comfort by ensuring they remain awake while receiving care.
Inspira's Vision for Respiratory Treatment
Joe Hayon, co-founder and President of Inspira Technologies, shared his excitement, stating, "We are thrilled to supply Westchester Medical Center with our FDA-cleared INSPIRA ART100 systems. This collaboration not only showcases our innovative technology but also demonstrates our capability to make a significant impact within a major health network." This sentiment underscores the mutual benefit both parties foresee in this partnership.
Commitment to Innovative Patient Care
David Spielvogel, MD, Section Chief of Cardiothoracic Surgery at Westchester Medical Center, expressed optimism about the collaboration, commenting, "This partnership exemplifies our commitment to investing in innovative technologies that provide the highest level of care. We aim to enhance our treatment of acute respiratory failure and improve patient outcomes with this advanced technology." This collaboration is expected to provide valuable insights into the INSPIRA ART100 system while improving healthcare standards.
About Westchester Medical Center Health Network
The Westchester Medical Center Health Network (WMCHealth) is a comprehensive healthcare system that includes multiple hospitals and specialized care facilities. With a specialization in advanced trauma care and a significant focus on patient safety, WMCHealth is equipped to leverage Inspira's technologies to enhance patient care across its network. The network employs a large team of healthcare providers, showcasing its capabilities in providing life-saving treatments.
About Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies is a trailblazer in medical technology, particularly in life support and respiratory treatments. The company has introduced the Augmented Respiration Technology (INSPIRA™ ART), which has the potential to revolutionize the mechanical ventilation market, valued at $19 billion. Each year, approximately 20 million patients experience acute respiratory failure, many of whom depend on mechanical ventilators. INSPIRA ART offers a remarkable alternative by stabilizing oxygen saturation levels in minutes, significantly improving the patient experience.
Innovative Products and Technologies
The INSPIRA™ ART100 system has already gained FDA 510(k) clearance for use in Cardiopulmonary Bypass procedures and has received the Israeli AMAR certification for similar uses. With a range of additional products and technologies in development, including the INSPIRA™ ART500 and HYLA™ blood sensor, Inspira is positioned to lead advancements in treatment for acute respiratory conditions.
Frequently Asked Questions
What is the purpose of the collaboration between Inspira and Westchester Medical Center?
The collaboration aims to assess the functionality and performance of the INSPIRA ART100 systems in real clinical settings, enhancing patient care.
What is INSPIRA™ ART technology?
INSPIRA™ ART is an innovative technology designed to treat acute respiratory failure by stabilizing oxygen levels quickly without the use of mechanical ventilators.
What certifications does the INSPIRA™ ART100 system have?
It has obtained FDA 510(k) clearance for Cardiopulmonary Bypass and AMAR certification in Israel for similar procedures.
How does Inspira's technology benefit patients?
Inspira's technology allows patients to remain awake during treatment while quickly restoring their oxygen saturation levels, making the treatment process more comfortable.
Where can I find more information about Inspira Technologies?
For more details on Inspira Technologies and their innovative solutions, visit their corporate website.
